Stockreport

Zafgen launches mid-stage study of ZGN-1061 in type 2 diabetics; shares ahead 5% after hours [Seeking Alpha]

ZAFGEN INC  (ZFGN) 
Last zafgen inc earnings: 3/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: zafgen.gcs-web.com/investor-relations
PDF Zafgen launches mid-stage study of ZGN-1061 in type 2 diabetics; shares ahead 5% after hoursZafgen (NASDAQ:ZFGN)initiates a Phase 2 clinical trial assessing the ability [Read more]